High-performance Liquid Chromatography (HPLC) 2018 Global Market Outlook,Research,Trends and Forecast to 2022

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ High-performance Liquid Chromatography (HPLC) 2018 Global Market Outlook,Research,Trends and Forecast to 2022”.

Description:

The High-performance Liquid Chromatography (HPLC) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, High-performance Liquid Chromatography (HPLC) market size to maintain the average annual growth rate of 2.96% from 2620 million $ in 2014 to 2860 million $ in 2017, The analysts believe that in the next few years, High-performance Liquid Chromatography (HPLC) market size will be further expanded, we expect that by 2022, The market size of the High-performance Liquid Chromatography (HPLC) will reach 3340 million $.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3084702-global-high-performance-liquid-chromatography-hplc-market-report-2018

For more information or any query mail at sales@wiseguyreports.com

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

Sections:-

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail
Agilent
Waters
Shimadzu
Thermo Fisher
PerkinElmer
Hitachi
Jasco
Knauer
Bekman
YoungLin
GBC
Gilson
SCIEX
Elite
East & West Analytical
Wufeng Scientific
Surwit
KeJie
Fuli Analytical
BFRL
Unimicrotech
Labtech
Wenfen

Continue…..

Complete Report Details @ https://www.wiseguyreports.com/reports/3084702-global-high-performance-liquid-chromatography-hplc-market-report-2018

Table Of Contents – Major Key Points

Section 1 High-performance Liquid Chromatography (HPLC) Product Definition

Section 2 Global High-performance Liquid Chromatography (HPLC) Market Manufacturer Share and Market Overview
2.1 Global Manufacturer High-performance Liquid Chromatography (HPLC) Shipments
2.2 Global Manufacturer High-performance Liquid Chromatography (HPLC) Business Revenue
2.3 Global High-performance Liquid Chromatography (HPLC) Market Overview

Section 3 Manufacturer High-performance Liquid Chromatography (HPLC) Business Introduction
3.1 Agilent High-performance Liquid Chromatography (HPLC) Business Introduction
3.1.1 Agilent High-performance Liquid Chromatography (HPLC) Shipments, Price, Revenue and Gross profit 2014-2017
3.1.2 Agilent High-performance Liquid Chromatography (HPLC) Business Distribution by Region
3.1.3 Agilent Interview Record
3.1.4 Agilent High-performance Liquid Chromatography (HPLC) Business Profile
3.1.5 Agilent High-performance Liquid Chromatography (HPLC) Product Specification
3.2 Waters High-performance Liquid Chromatography (HPLC) Business Introduction
3.2.1 Waters High-performance Liquid Chromatography (HPLC) Shipments, Price, Revenue and Gross profit 2014-2017
3.2.2 Waters High-performance Liquid Chromatography (HPLC) Business Distribution by Region
3.2.3 Interview Record
3.2.4 Waters High-performance Liquid Chromatography (HPLC) Business Overview
3.2.5 Waters High-performance Liquid Chromatography (HPLC) Product Specification
3.3 Shimadzu High-performance Liquid Chromatography (HPLC) Business Introduction
3.3.1 Shimadzu High-performance Liquid Chromatography (HPLC) Shipments, Price, Revenue and Gross profit 2014-2017
3.3.2 Shimadzu High-performance Liquid Chromatography (HPLC) Business Distribution by Region
3.3.3 Interview Record
3.3.4 Shimadzu High-performance Liquid Chromatography (HPLC) Business Overview
3.3.5 Shimadzu High-performance Liquid Chromatography (HPLC) Product Specification
3.4 Thermo Fisher High-performance Liquid Chromatography (HPLC) Business Introduction
3.5 PerkinElmer High-performance Liquid Chromatography (HPLC) Business Introduction
3.6 Hitachi High-performance Liquid Chromatography (HPLC) Business Introduction

Section 4 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.1.2 Canada High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.2 South America Country
4.2.1 South America High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.3 Asia Country
4.3.1 China High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.3.2 Japan High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.3.3 India High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.3.4 Korea High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.4 Europe Country
4.4.1 Germany High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.4.2 UK High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.4.3 France High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.4.4 Italy High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.4.5 Europe High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.5 Other Country and Region
4.5.1 Middle East High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.5.2 Africa High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.5.3 GCC High-performance Liquid Chromatography (HPLC) Market Size and Price Analysis 2014-2017
4.6 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Region Level) Analysis 2014-2017
4.7 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Region Level) Analysis

Section 5 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Product Type Level)
5.1 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Product Type Level) Market Size 2014-2017
5.2 Different High-performance Liquid Chromatography (HPLC) Product Type Price 2014-2017
5.3 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Product Type Level) Analysis

Section 6 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Industry Level)
6.1 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Industry Level) Market Size 2014-2017
6.2 Different Industry Price 2014-2017
6.3 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Industry Level) Analysis

Section 7 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Channel Level)
7.1 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Channel Level) Sales Volume and Share 2014-2017
7.2 Global High-performance Liquid Chromatography (HPLC) Market Segmentation (Channel Level) Analysis

Continue……

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Nylon 6 & 66 Market 2018 : Manufacturers Analysis,Applications,Demand by Regions & Forecasts to 2022

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ —

WiseGuyReports.Com Publish a New Market Research Report On –“ Nylon 6 & 66 Market 2018 : Manufacturers Analysis,Applications,Demand by Regions & Forecasts to 2022”.

Description:

The Nylon 6 & 66 industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Nylon 6 & 66 market size to maintain the average annual growth rate of xxx from xxx million $ in 2014 to xxx million $ in 2017, The analysts believe that in the next few years, Nylon 6 & 66 market size will be further expanded, we expect that by 2022, The market size of the Nylon 6 & 66 will reach xxx million $.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3084720-global-nylon-6-66-market-report-2018

For more information or any query mail at sales@wiseguyreports.com

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

Sections:-

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail
Invista
Ascend
Solvay
BASF
Asahi Kasei
Dupont
Radici Group
Shenma
Hua Yang
Honeywell
Royal DSM N.V
Lanxess
Clariant Corporation
Unitika
DOMO Chemicals
Firestone Textiles Company
Grupa Azoty
LIBOLON
Polymeric Resources Corporation (PRC)
UBE

Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Continue…..

Complete Report Details @ https://www.wiseguyreports.com/reports/3084720-global-nylon-6-66-market-report-2018

Table Of Contents – Major Key Points

Section 1 Nylon 6 & 66 Product Definition

Section 2 Global Nylon 6 & 66 Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Nylon 6 & 66 Shipments
2.2 Global Manufacturer Nylon 6 & 66 Business Revenue
2.3 Global Nylon 6 & 66 Market Overview

Section 3 Manufacturer Nylon 6 & 66 Business Introduction
3.1 Invista Nylon 6 & 66 Business Introduction
3.1.1 Invista Nylon 6 & 66 Shipments, Price, Revenue and Gross profit 2014-2017
3.1.2 Invista Nylon 6 & 66 Business Distribution by Region
3.1.3 Invista Interview Record
3.1.4 Invista Nylon 6 & 66 Business Profile
3.1.5 Invista Nylon 6 & 66 Product Specification
3.2 Ascend Nylon 6 & 66 Business Introduction
3.2.1 Ascend Nylon 6 & 66 Shipments, Price, Revenue and Gross profit 2014-2017
3.2.2 Ascend Nylon 6 & 66 Business Distribution by Region
3.2.3 Interview Record
3.2.4 Ascend Nylon 6 & 66 Business Overview
3.2.5 Ascend Nylon 6 & 66 Product Specification
3.3 Solvay Nylon 6 & 66 Business Introduction
3.3.1 Solvay Nylon 6 & 66 Shipments, Price, Revenue and Gross profit 2014-2017
3.3.2 Solvay Nylon 6 & 66 Business Distribution by Region
3.3.3 Interview Record
3.3.4 Solvay Nylon 6 & 66 Business Overview
3.3.5 Solvay Nylon 6 & 66 Product Specification
3.4 BASF Nylon 6 & 66 Business Introduction
3.5 Asahi Kasei Nylon 6 & 66 Business Introduction
3.6 Dupont Nylon 6 & 66 Business Introduction

Section 4 Global Nylon 6 & 66 Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.1.2 Canada Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.2 South America Country
4.2.1 South America Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.3 Asia Country
4.3.1 China Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.3.2 Japan Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.3.3 India Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.3.4 Korea Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.4 Europe Country
4.4.1 Germany Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.4.2 UK Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.4.3 France Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.4.4 Italy Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.4.5 Europe Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.5 Other Country and Region
4.5.1 Middle East Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.5.2 Africa Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.5.3 GCC Nylon 6 & 66 Market Size and Price Analysis 2014-2017
4.6 Global Nylon 6 & 66 Market Segmentation (Region Level) Analysis 2014-2017
4.7 Global Nylon 6 & 66 Market Segmentation (Region Level) Analysis

Section 5 Global Nylon 6 & 66 Market Segmentation (Product Type Level)
5.1 Global Nylon 6 & 66 Market Segmentation (Product Type Level) Market Size 2014-2017
5.2 Different Nylon 6 & 66 Product Type Price 2014-2017
5.3 Global Nylon 6 & 66 Market Segmentation (Product Type Level) Analysis

Section 6 Global Nylon 6 & 66 Market Segmentation (Industry Level)
6.1 Global Nylon 6 & 66 Market Segmentation (Industry Level) Market Size 2014-2017
6.2 Different Industry Price 2014-2017
6.3 Global Nylon 6 & 66 Market Segmentation (Industry Level) Analysis

Section 7 Global Nylon 6 & 66 Market Segmentation (Channel Level)
7.1 Global Nylon 6 & 66 Market Segmentation (Channel Level) Sales Volume and Share 2014-2017
7.2 Global Nylon 6 & 66 Market Segmentation (Channel Level) Analysis

Continue……

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Dental Implants 2018 Global Market Net Worth US$ 6680 million Forecast By 2022

WiseGuyReports.Com Publish a New Market Research Report On –“ Dental Implants 2018 Global Market Net Worth US$ 6680 million Forecast By 2022”.

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ —

Description:

The Dental Implants industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Dental Implants market size to maintain the average annual growth rate of 8.76% from 3564 million $ in 2014 to 4585 million $ in 2017, The analysts believe that in the next few years, Dental Implants market size will be further expanded, we expect that by 2022, The market size of the Dental Implants will reach 6680 million $.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3084691-global-dental-implants-market-report-2018

For more information or any query mail at sales@wiseguyreports.com

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

Sections:-

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail
Straumann
Nobel Biocare(Danaher)
Dentsply/Astra
Biomet
Zimmer
Osstem
GC
Zest
Dyna Dental
Kyocera Medical
Alpha-Bio
Southern Implants
B&B Dental
Neobiotech
Xige Medical

Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Continue…..

Complete Report Details @ https://www.wiseguyreports.com/reports/3084691-global-dental-implants-market-report-2018

Table Of Contents – Major Key Points

Section 1 Dental Implants Product Definition

Section 2 Global Dental Implants Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Dental Implants Shipments
2.2 Global Manufacturer Dental Implants Business Revenue
2.3 Global Dental Implants Market Overview

Section 3 Manufacturer Dental Implants Business Introduction
3.1 Straumann Dental Implants Business Introduction
3.1.1 Straumann Dental Implants Shipments, Price, Revenue and Gross profit 2014-2017
3.1.2 Straumann Dental Implants Business Distribution by Region
3.1.3 Straumann Interview Record
3.1.4 Straumann Dental Implants Business Profile
3.1.5 Straumann Dental Implants Product Specification
3.2 Nobel Biocare(Danaher) Dental Implants Business Introduction
3.2.1 Nobel Biocare(Danaher) Dental Implants Shipments, Price, Revenue and Gross profit 2014-2017
3.2.2 Nobel Biocare(Danaher) Dental Implants Business Distribution by Region
3.2.3 Interview Record
3.2.4 Nobel Biocare(Danaher) Dental Implants Business Overview
3.2.5 Nobel Biocare(Danaher) Dental Implants Product Specification
3.3 Dentsply/Astra Dental Implants Business Introduction
3.3.1 Dentsply/Astra Dental Implants Shipments, Price, Revenue and Gross profit 2014-2017
3.3.2 Dentsply/Astra Dental Implants Business Distribution by Region
3.3.3 Interview Record
3.3.4 Dentsply/Astra Dental Implants Business Overview
3.3.5 Dentsply/Astra Dental Implants Product Specification
3.4 Biomet Dental Implants Business Introduction
3.5 Zimmer Dental Implants Business Introduction
3.6 Osstem Dental Implants Business Introduction

Section 4 Global Dental Implants Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Dental Implants Market Size and Price Analysis 2014-2017
4.1.2 Canada Dental Implants Market Size and Price Analysis 2014-2017
4.2 South America Country
4.2.1 South America Dental Implants Market Size and Price Analysis 2014-2017
4.3 Asia Country
4.3.1 China Dental Implants Market Size and Price Analysis 2014-2017
4.3.2 Japan Dental Implants Market Size and Price Analysis 2014-2017
4.3.3 India Dental Implants Market Size and Price Analysis 2014-2017
4.3.4 Korea Dental Implants Market Size and Price Analysis 2014-2017
4.4 Europe Country
4.4.1 Germany Dental Implants Market Size and Price Analysis 2014-2017
4.4.2 UK Dental Implants Market Size and Price Analysis 2014-2017
4.4.3 France Dental Implants Market Size and Price Analysis 2014-2017
4.4.4 Italy Dental Implants Market Size and Price Analysis 2014-2017
4.4.5 Europe Dental Implants Market Size and Price Analysis 2014-2017
4.5 Other Country and Region
4.5.1 Middle East Dental Implants Market Size and Price Analysis 2014-2017
4.5.2 Africa Dental Implants Market Size and Price Analysis 2014-2017
4.5.3 GCC Dental Implants Market Size and Price Analysis 2014-2017
4.6 Global Dental Implants Market Segmentation (Region Level) Analysis 2014-2017
4.7 Global Dental Implants Market Segmentation (Region Level) Analysis

Section 5 Global Dental Implants Market Segmentation (Product Type Level)
5.1 Global Dental Implants Market Segmentation (Product Type Level) Market Size 2014-2017
5.2 Different Dental Implants Product Type Price 2014-2017
5.3 Global Dental Implants Market Segmentation (Product Type Level) Analysis

Section 6 Global Dental Implants Market Segmentation (Industry Level)
6.1 Global Dental Implants Market Segmentation (Industry Level) Market Size 2014-2017
6.2 Different Industry Price 2014-2017
6.3 Global Dental Implants Market Segmentation (Industry Level) Analysis

Section 7 Global Dental Implants Market Segmentation (Channel Level)
7.1 Global Dental Implants Market Segmentation (Channel Level) Sales Volume and Share 2014-2017
7.2 Global Dental Implants Market Segmentation (Channel Level) Analysis

Continue……

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Hydroxyapatite-coated Femoral Components Market 2018 Share, Trend, Segmentation and Forecast to 2023

Hydroxyapatite-coated Femoral Components Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025

PUNE, MAHARASHTRA, INDIA, March 27, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Hydroxyapatite-coated Femoral Components Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” reports to its database.

This report provides in depth study of “Hydroxyapatite-coated Femoral Components market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Hydroxyapatite-coated Femoral Components Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Hydroxyapatite-coated Femoral Components refers to a hard tissue implant material coated with hydroxyapatite on femur components using titanium as a base and physically and chemically. After the material is implanted into the human body, the titanium alloy can provide sufficient mechanical strength, the surface of the hydroxyapatite coating is easy to combine with the human bone, in the human bone surface induced new bone formation, generally months to induce new bone formation.

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Stryker
Zimmer Biomet
Nano Interface Technology
DePuy Synthes
Smith & Nephew
MicroPort
Exactech
Kycera Medical

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2388156-global-hydroxyapatite-coated-femoral-components-market-data-survey-report-2025

The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications

Major applications as follows:
Hospital
Clinic

Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

At any Query @ https://www.wiseguyreports.com/enquiry/2388156-global-hydroxyapatite-coated-femoral-components-market-data-survey-report-2025

Table of Contents

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 Key Manufacturers
3.1 Stryker
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Zimmer Biomet
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Nano Interface Technology
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 DePuy Synthes
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Smith & Nephew
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 MicroPort
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Exactech
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Kycera Medical
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application
4.1 Hospital
4.1.1 Overview
4.1.2 Hospital Market Size and Forecast
4.2 Clinic
4.2.1 Overview
4.2.2 Clinic Market Size and Forecast

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2388156

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Chondroitin Sulfate Market 2018 Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

Chondroitin Sulfate Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Chondroitin Sulfate Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” reports to its database.

This report provides in depth study of “Chondroitin Sulfate market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Chondroitin Sulfate Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Chondroitin Sulfate is a Sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). It is usually found attached to proteins as part of a proteoglycan. A chondroitin chain can have over 100 individual sugars, each of which can be Sulfated in variable positions and quantities. Chondroitin Sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine, chondroitin Sulfate has become a widely used dietary supplement for treatment of osteoarthritis.

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
WanTuMing Biological
SANXIN
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek (Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2417578-global-chondroitin-sulfate-market-data-survey-report-2025

The global Chondroitin Sulfate market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications

Major applications as follows:
Pharmaceutical
Dietary Supplements
Cosmetics
Veterinary Use

Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa

At any Query @ https://www.wiseguyreports.com/enquiry/2417578-global-chondroitin-sulfate-market-data-survey-report-2025

Table of Contents

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 Key Manufacturers
3.1 WanTuMing Biological
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 SANXIN
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 TSI Group
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Yantai Dongcheng
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Focus Chem
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 YBCC
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Runxin Biotechnology
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 ISBA
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Huiwen
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 QJBCHINA
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Meitek (Synutra International)
3.12 Hengjie Bio-Pharmaceuticals
3.13 Nippon Zoki
3.14 GGI
3.15 Summit Nutritionals
3.16 Sioux Pharm
3.17 Ruikangda Biochemical
3.18 Guanglong Biochem
3.19 Pacific Rainbow

4 Major Application
4.1 Pharmaceutical
4.1.1 Overview
4.1.2 Pharmaceutical Market Size and Forecast
4.2 Dietary Supplements
4.2.1 Overview
4.2.2 Dietary Supplements Market Size and Forecast
4.3 Cosmetics
4.3.1 Overview
4.3.2 Cosmetics Market Size and Forecast
4.4 Veterinary Use
4.4.1 Overview
4.4.2 Veterinary Use Market Size and Forecast

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2417578

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Dry Eye Disease Pharmaceutical and Healthcare Pipeline Review H1

Dry Eye Disease Therapeutic and Drug Pipeline Review H1

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ — Summary
Keratoconjunctivitis sicca (KCS) or dry eye disease (DED) or dry eye syndrome (DES) is a condition in which a person experience desiccation of the conjunctiva and cornea due to an inadequate tear film. Symptoms include hyperemia, mucoid discharge, ocular irritation, photophobia and blurry vision. Risk factors include age, wearing contact lenses and low levels of vitamin A. Treatment includes artificial tear substitutes, topical anti-inflammatory agents, secretagogues and immunosuppressants.

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3079805-keratoconjunctivitis-sicca-dry-eye-pipeline-review-h1-2018

The Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Keratoconjunctivitis sicca (Dry Eye) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 9, 20, 8, 30, 3 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecule, respectively.

Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology).
– The pipeline guide reviews pipeline therapeutics for Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
Introduction 5
Keratoconjunctivitis sicca (Dry Eye) – Overview 6
Keratoconjunctivitis sicca (Dry Eye) – Therapeutics Development 7
Keratoconjunctivitis sicca (Dry Eye) – Therapeutics Assessment 20
Keratoconjunctivitis sicca (Dry Eye) – Companies Involved in Therapeutics Development 30
Keratoconjunctivitis sicca (Dry Eye) – Drug Profiles 47
Keratoconjunctivitis sicca (Dry Eye) – Dormant Projects 194
Keratoconjunctivitis sicca (Dry Eye) – Discontinued Products 198
Keratoconjunctivitis sicca (Dry Eye) – Product Development Milestones 199
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3079805-keratoconjunctivitis-sicca-dry-eye-pipeline-review-h1-2018

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Glaucoma Pharmaceutical and Healthcare Analysis Information

Glaucoma Pharmaceutical and Healthcare Pipeline Review H1

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ — Summary
Glaucoma is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from glaucoma is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The most important risk factors include age, elevated eye pressure, African ancestry, thin cornea, family history of glaucoma. Signs and symptoms include eye pain, nausea and vomiting (accompanying the severe eye pain), sudden onset of visual disturbance, often in low light, blurred vision and reddening of the eye.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3079804-glaucoma-pipeline-review-h1-2018

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Glaucoma – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Glaucoma (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Glaucoma (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Glaucoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 11, 20, 8, 58, 14 and 4 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 10 and 3 molecules, respectively.

Glaucoma (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Glaucoma (Ophthalmology).
– The pipeline guide reviews pipeline therapeutics for Glaucoma (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Glaucoma (Ophthalmology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Glaucoma (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Glaucoma (Ophthalmology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Glaucoma (Ophthalmology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Glaucoma (Ophthalmology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
Introduction 5
Glaucoma – Overview 6
Glaucoma – Therapeutics Development 7
Glaucoma – Therapeutics Assessment 24
Glaucoma – Companies Involved in Therapeutics Development 36
Glaucoma – Drug Profiles 62
Glaucoma – Dormant Projects 267
Glaucoma – Discontinued Products 273
Glaucoma – Product Development Milestones 275
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3079804-glaucoma-pipeline-review-h1-2018

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Glomerulonephritis Drugs and Companies Pipeline Review H1 2018

Glomerulonephritis Assessment and Therapeutics Pipeline Review H1 2018

PUNE, INDIA, March 27, 2018 /EINPresswire.com/ — Summary
Glomerulonephritis is also known as glomerular nephritis (GN) or glomerular disease. It is a disease of the kidney, characterized by inflammation of the glomeruli. Causes of glomerulonephritis include Streptococcal infection of the throat known as strep throat, immune diseases, such as lupus, Type 1 diabetes and type 2 diabetes and viruses, such as HIV, hepatitis B virus, and hepatitis C virus. Factors that increase chances of getting glomerulonephritis include family history of glomerulonephritis, the presence of a known cause of glomerulonephritis and high blood pressure. Common symptoms of glomerulonephritis are blood in the urine (dark, rust-colored, or brown urine), foamy urine, swelling (edema) of the face, eyes, ankles, feet, legs, or abdomen. Treatment will depend on the cause of glomerulonephritis such as medications, lifestyle changes, dialysis and transplant.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3079803-glomerulonephritis-pipeline-review-h1-2018

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Glomerulonephritis – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Glomerulonephritis (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Glomerulonephritis (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 15, 7, 12 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 3 molecules, respectively.

Glomerulonephritis (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Glomerulonephritis (Genito Urinary System And Sex Hormones).
– The pipeline guide reviews pipeline therapeutics for Glomerulonephritis (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Glomerulonephritis (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Glomerulonephritis (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Glomerulonephritis (Genito Urinary System And Sex Hormones)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Glomerulonephritis (Genito Urinary System And Sex Hormones).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Glomerulonephritis (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
Introduction 4
Glomerulonephritis – Overview 5
Glomerulonephritis – Therapeutics Development 6
Glomerulonephritis – Therapeutics Assessment 15
Glomerulonephritis – Companies Involved in Therapeutics Development 25
Glomerulonephritis – Drug Profiles 37
Glomerulonephritis – Dormant Projects 181
Glomerulonephritis – Discontinued Products 183
Glomerulonephritis – Product Development Milestones 184
Appendix 195
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3079803-glomerulonephritis-pipeline-review-h1-2018

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

LightningBrainSeries Website Now Active

“The Girl With The Lightning Brain”

LightningBrainSeries Website Now Active

CHICAGO, IL, UNITED STATES, March 26, 2018 /EINPresswire.com/ — Author Cliff Ratza’s debut action-adventure thriller – "The Girl With The Lightning Brain" – now has a companion Website that is designed to engage the reader audience. Please visit LightningBrainSeries.com to order the book, or to learn more about the series, first book, and author. And when you’re ready, please visit to enter the first contest. You are also invited to use the Blog page to help us reach out to more readers.

As you enter the world of our main character – Electra Kittner – you will soon discover why she is exceptional, and why she must keep her secret hidden. And she does just that, though she needs to use all her abilities as she battles Middle East Terrorism and the "Techno-Plague" while keeping an intolerant and intrusive government at bay.

The series is "plausible socio-political and science future-projection" that should appeal to a wide audience. We invite you to shapeshift your view into the future as the novel chronicles Electra's death-defying journey, from birth to a shocking conclusion on her 21st birthday, that demands an immediate sequel. Thanks for joining us.

About the Author:
Author Cliff Ratza characterizes himself a "simple scholar," having parlayed multiple degrees (math and physics, business and computer science) into a business career spanning numerous jobs, companies, and industries. He grew up in Chicago, graduating from top Illinois universities, then launched his business career. He returned to Chicago, where he teaches at several universities while continuing to work for corporations. He subsequently started a sales and marketing consulting business, and most recently added a writing career to his resume.

Cliff has written extensively throughout his career. He has published articles in four professional journals, writes copy for client Websites, and develops press releases or newsletters. He has already written three novels in his ground-breaking "Lightning Brain Series." The first, "The Girl with the Lightning Brain," is now available in print or e-book format at bookstores or online. Please visit www.authorcentrix.com or call 8885040951 for more details when you are ready to buy.

Cliff dedicates the series to readers everywhere and invites them to visit the "Lightning Brain" Website, www.lightningbrainseries.com, to learn more about the books or enter reader contests.

Product details
Paperback: 546 pages
Publisher: AuthorCentrix, Inc. (February 13, 2018)
Language: English
ISBN-10: 1641333316
ISBN-13: 978-1641333313
Product Dimensions: 6 x 1.2 x 9 inches

Book Availability:
Amazon – http://goo.gl/emqcgx
Barnes & Noble – http://goo.gl/XfnZro

Clifford Leonard Ratza
.
8885040951
email us here


Source: EIN Presswire

SMi’s Pre-Filled Syringes East Coast Conference, April, Boston – attendee list released

Pre-Filled Syringes East Coast 2018

Pre-Filled Syringes East Coast 2018

BOSTON, MA, USA, March 26, 2018 /EINPresswire.com/ — SMi Group reports: Doors open to the 5th annual Pre-Filled Syringes East Coast conference and exhibition in just few weeks' time (April 11-12, Boston) and attendee list has been released. Here is a snap-shot of companies participating and full list can be found on the event website http://www.pfsamericas.com/ein

[ Alexion Pharmaceuticals | Alkermes | Amgen | Aptar Pharma | Astrazeneca | Baxter Healthcare | BCM Group LLC |
BD Medical – Pharmaceutical Systems | Biogen Idec | Eli Lilly and Company | GSK Pharma | Janssen | kaleo, Inc. | Key Tech | Luitpold Pharmaceuticals | MedImmune Inc | Merck | Momenta Pharmaceuticals | Nemera | NN Precision Engineered Products | Novartis | Otsuka Pharmaceuticals | Pfizer | Regeneron Pharmaceuticals Inc | Sanofi Pharmaceuticals | Schott AG | Schreiner Group LP | Shire US Inc | Takeda | TESARO | Teva Pharmaceuticals USA + many others! ]

If there is an interested in attending the industry leading meeting, organisers would advise to book as soon as possible as places will sell out soon. VIP packages and special rates available for group bookings, pharmaceutical companies and those wishing to attend conference and interactive workshops.

Here is the brief overview of what to expect at the Pre-Filled Syringes East Coast conference
Day 1 will explore manufacturing challenges and solutions; provide guidance on integrating QbD principles, and discuss the trend towards a rise in biologics and its implications for the PFS industry

Day 2 explores key issues surrounding human factors and end user considerations; smart labelling solutions; and the future of parenteral drug delivery and digitally connected devices.

PLUS: Two pre-conference (April 10) interactive workshops on
(1) Design Considerations for the World Outside the Clinic hosted by Battelle;
(2) Human Factors for Connected Drug Delivery Systems hosted by Cambridge Consultants.

Visit Pre-Filled Syringes East Coast conference website for further details
http://www.pfsamericas.com/ein

Contact:
+44 (0)20 7827 6000
ldurneva@smi-online.co.uk

STAY CONNECTED
LinkedIn – search 'SMi Pharma'
Twitter – @SMIpharm and #smipfsusa

————————————————————————————————–
Pre-Filled Syringes East Coast | April 11 – 12, 2018 | Boston, USA
http://www.pfsamericas.com/ein
————————————————————————————————–

Luda Durneva
SMi Group
email us here
+44 (0)20 7827 6000


Source: EIN Presswire